Operose Advisors’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-32
Closed -$21.8K 624
2026
Q1
$21.8K Buy
+32
New +$22.1K 0.01% 349
2025
Q1
Sell
-10
Closed -$4.69K 435
2024
Q4
$4.69K Sell
10
-44
-81% -$22.1K ﹤0.01% 357
2024
Q3
$28.5K Hold
54
0.01% 354
2024
Q2
$23.5K Hold
54
0.01% 334
2024
Q1
$25.8K Hold
54
0.01% 343
2023
Q4
$25.3K Hold
54
0.01% 322
2023
Q3
$23.8K Buy
+54
New +$23.7K 0.01% 444
2023
Q1
Sell
-50
Closed -$27.3K 373
2022
Q4
$27.3K Hold
50
0.01% 197
2022
Q3
$24K Hold
50
0.02% 203
2022
Q2
$24K Hold
50
0.02% 190
2022
Q1
$22K Hold
50
0.02% 206
2021
Q4
$19K Buy
+50
New +$18.6K 0.02% 214

Other funds holding NOC

Operose Advisors's NOC Position: Q2 2026 in Review

Operose Advisors sold out of Northrop Grumman (NOC) in Q2 2026, closing a stake of 32 shares — an estimated $21.8K sold.

Operose Advisors first reported a position in NOC in Q4 2021 and held it in 12 quarters. The position peaked at $28.5K in Q3 2024. 1,800 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Operose Advisors reported no remaining Northrop Grumman position as of Q2 2026 after selling out during the quarter.
  • Operose Advisors sold 32 Northrop Grumman shares in Q2 2026, an estimated $21.8K.
  • Operose Advisors first reported a position in Northrop Grumman in Q4 2021 and held it in 12 quarters.
  • Operose Advisors's Northrop Grumman position peaked at $28.5K in Q3 2024.
  • 1,800 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.